Development of Stabilized AAV Capsids for Vector Engineering

被引：0
|
作者：
Pacouret, Simon [1 ]
Eid, Fatma Elzahraa [1 ]
Donahoe, William [1 ]
Chan, Ken Y. [1 ]
Wu, Jason [1 ]
Zheng, Qingxia [1 ]
Keyes, Casey [1 ]
Brauer, Pamela [1 ]
Chen, Albert [1 ]
Chan, Yujia A. [1 ]
Deverman, Benjamin [1 ]
机构：
[1] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
44
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [21] Engineering the AAV capsid to optimize vector-host-interactions
    Buening, Hildegard
    Huber, Anke
    Zhang, Liang
    Meumann, Nadja
    Hacker, Ulrich
    CURRENT OPINION IN PHARMACOLOGY, 2015, 24 : 94 - 104
  • [22] Engineering Micro-Dystrophin AAV Vector for Clinical Translation
    Hakim, Chady H.
    Yue, Yongping
    Lai, Yi
    Duan, Dongsheng
    MOLECULAR THERAPY, 2015, 23 : S159 - S160
  • [23] Artificial Intelligence-Based Approaches for AAV Vector Engineering
    Tan, Fangzhi
    Dong, Yue
    Qi, Jieyu
    Yu, Wenwu
    Chai, Renjie
    ADVANCED SCIENCE, 2025, 12 (09)
  • [24] Engineering CNS-targeted AAV capsids from massively diverse libraries using machine learning
    Huss, D. J.
    Packard, T. A.
    Cates, E.
    Lee, M.
    Bazinet, J. E.
    Stein, K. C.
    Jiang, Y.
    Andrade, M. F. L.
    Long, T. J.
    Vigneault, F.
    Hause, R.
    Briggs, A. W.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A32 - A33
  • [25] Accurate measurement of NAb status against AAV vector capsids and an approach toward managing its inhibitory effect
    Mizukami, H.
    Mimuro, J.
    Hishikawa, S.
    Ikemoto, T.
    Uchibori, R.
    Tsukahara, T.
    Urabe, M.
    Kume, A.
    Sakata, A.
    Ohmori, T.
    Madoiwa, S.
    Sakata, Y.
    Ozawa, K.
    HUMAN GENE THERAPY, 2013, 24 (12) : A36 - A36
  • [26] The Potential Role of Surface-Exposed Tyrosine Residues on AAV Capsids in the Diminution of Vector Neutralization by Human Antibodies
    Yang, Hua
    Rambhai, Himanshu K.
    Ashby, Frederick J.
    Ling, Chen
    Qing, Keyun
    Srivastava, Arun
    MOLECULAR THERAPY, 2019, 27 (04) : 61 - 61
  • [27] Identification of novel AAV capsids for treatment of lysosomal disorders
    Chen, Daphne
    Padegimas, Linas
    Zaric, Violeta
    Miller, Timothy J.
    Gray, Steven
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S31 - S31
  • [28] Advances in AAV Vector Development for Gene Therapy in the Retina
    Day, Timothy P.
    Byrne, Leah C.
    Schaffer, David V.
    Flannery, John G.
    RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2014, 801 : 687 - 693
  • [29] Development of Mutant AAV-DJ Capsids with Better Transduction Efficiency for Local and Systemic Delivery
    Duzenli, Ozgun Firat
    Zhang Lianwen
    Peng, Kah-Whye
    Aslanidi, George
    MOLECULAR THERAPY, 2024, 32 (04) : 685 - 685
  • [30] Analytical characterization of full, intermediate, and empty AAV capsids
    Aisleen McColl-Carboni
    Serena Dollive
    Sarah Laughlin
    Rudenc Lushi
    Michael MacArthur
    Shanshan Zhou
    Jeffrey Gagnon
    Christopher A. Smith
    Brenda Burnham
    Robert Horton
    Dimpal Lata
    Brianna Uga
    Kalyani Natu
    Emmanuela Michel
    Celia Slater
    Evan DaSilva
    Robert Bruccoleri
    Tim Kelly
    James B. McGivney
    Gene Therapy, 2024, 31 : 285 - 294
12345